NCT07221071

Brief Summary

The purpose of this study is to evaluate if a brief mindfulness intervention before and after surgery would impact patient emotional wellbeing, quality of life, and biomarkers measured before and after surgery by finger prick collection and surveys.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 27, 2025

Completed
Last Updated

October 27, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

October 21, 2025

Last Update Submit

October 23, 2025

Conditions

Keywords

Cancer SurgeryMindfulnessBreast Cancer

Outcome Measures

Primary Outcomes (1)

  • Patient Anxiety

    To measure the impact of a mindfulness intervention instituted prior to surgery on patient anxiety for newly diagnosed breast cancer patients, using the PROMIS anxiety questionnaire \[Emotional Distress - Anxiety - Short Form 8a answer options are: Never, Rarely, Sometimes, Often, Always\].

    3 months

Secondary Outcomes (3)

  • Patient Depression

    3 months

  • Psychosocial wellbeing

    3 months

  • Stress biomarker

    3 months

Other Outcomes (3)

  • Exploratory

    3 months

  • Self-Kindness questionnaire

    3 months

  • Emotional Reactivity/Regulation and Mindfulness Awareness

    3 months

Study Arms (2)

Mindfulness Arm

EXPERIMENTAL

Brief video and audio practice of mindfulness

Behavioral: Mindfulness Arm

Health Videos - Mike Evans

PLACEBO COMPARATOR

Brief videos focusing on health and wellness

Other: Control group placebo

Interventions

Mindfulness ArmBEHAVIORAL

Participants will be instructed to watch four brief breast cancer specific educational mindfulness videos (within the first week of randomization), listen to guided audio recordings of different mindfulness meditations at least 3 times per week throughout the intervention period (which lasts until the Time 3 Assessment), and complete brief, post-listening written reflections in a journal (NOW reflections) that is provided to them during the intervention period.

Mindfulness Arm

Participants will receive brief videos that focuses on general health behaviors. We will utilize the Mike Evans chalkboard videos (https://www.reframehealthlab.com/category/whiteboard-health-videos/) as the control for this group. Participants will view the Mike Evans videos within the first week following randomization. The participants will be assigned to watch 10 videos located on the Group B study website. Topics range from cancer fatigue, healthy eating, benefits of exercise, and the science of happiness.

Health Videos - Mike Evans

Eligibility Criteria

Age20 Years - 85 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Females \>20 and \< 85 years of age
  • History of contralateral breast cancer in the past is acceptable
  • Patients seeking second opinion for diagnosis are eligible
  • Clinical AJCC stage 0-III breast cancer
  • Patients who have an in breast tumor recurrence are eligible
  • English Speaking
  • Willing to fill out surveys required for the study
  • Gene mutation carriers are eligible
  • Neoadjuvant therapy patients are eligible

You may not qualify if:

  • AJCC Stage IV breast cancer
  • Unwilling to fill out surveys for the study
  • Patients with a distant recurrence
  • Patients unaware of their diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Endeavor Health

Evanston, Illinois, 60201, United States

Location

Related Publications (2)

  • Black DS, Slavich GM. Mindfulness meditation and the immune system: a systematic review of randomized controlled trials. Ann N Y Acad Sci. 2016 Jun;1373(1):13-24. doi: 10.1111/nyas.12998. Epub 2016 Jan 21.

    PMID: 26799456BACKGROUND
  • Bishop SR, Lau M, Shapiro S, et al. Mindfulness: A Proposed Ooperational Definition. Clinical Psychology: Science and Practice. 2004;11(3):230-241

    BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Katharine Yao, M.D

    Endeavor Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 21, 2025

First Posted

October 27, 2025

Study Start

August 5, 2021

Primary Completion

August 1, 2023

Study Completion

December 31, 2024

Last Updated

October 27, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations